{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:59:40Z","timestamp":1791961180048,"version":"4.3.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008667","name":"National Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Despite multiple therapeutic approaches, the presence of liver metastases carries a guarded prognosis, urgently necessitating further clinical and scientific research to develop curative interventions. The liver is an immunoprivileged organ that suppresses the effectiveness of immunotherapies in patients with hepatic metastases. Cancer immunotherapies have been successfully bolstered by low-dose radiotherapy (LDRT), which is capable of reprogramming the tumor microenvironment (TME) from an immunosuppressive to an immunostimulatory one. Likewise, LDRT may be able to revoke the immune privilege enjoyed by the liver, permitting successful immunotherapies there. Here, we first review challenges that face the treatment of liver metastases. We next outline emerging preclinical and clinical evidence supporting enhanced systemic tumor control of LDRT in the context of cancer immunotherapy. Finally, we will discuss the rationale of combining liver-directed LDRT with immunostimulatory strategies to overcome immune resistance and achieve better clinical response. This notion is supported by a recent case study in which a patient who had progressed following T cell therapy experienced a complete response after LDRT to the liver.<\/jats:p>","DOI":"10.3389\/fimmu.2021.812210","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T06:13:12Z","timestamp":1639548792000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases"],"prefix":"10.3389","volume":"12","author":[{"given":"Kewen","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hampartsoum B.","family":"Barsoumian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Bertolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Leuschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene J.","family":"Koay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan B.","family":"Ludmir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Pisipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany A.","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahum","family":"Puebla-Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angelica","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","article-title":"Liver Metastases","volume":"7","author":"Tsilimigras","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B2","article-title":"Liver Metastasis","volume-title":"StatPearls","author":"Griscom","year":"2021"},{"key":"B3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0301-4738.154367","article-title":"Uveal Melanoma: Estimating Prognosis","volume":"63","author":"Kaliki","year":"2015","journal-title":"Indian J Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal Melanoma: Trends in Incidence, Treatment, and Survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101760","DOI":"10.1016\/j.canep.2020.101760","article-title":"Epidemiology of Liver Metastases","volume":"67","author":"Horn","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e000537","DOI":"10.1136\/jitc-2020-000537","article-title":"Low-Dose Radiation Treatment Enhances Systemic Antitumor Immune Responses by Overcoming the Inhibitory Stroma","volume":"8","author":"Barsoumian","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"candisc.0003.2021","DOI":"10.1158\/2159-8290.CD-21-0003","article-title":"Low Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy","author":"Herrera","year":"2021","journal-title":"Cancer Discov"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3518","article-title":"Postablation Modulation After Single High-Dose Radiation Therapy Improves Tumor Control via Enhanced Immunomodulation","volume":"26","author":"Savage","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2021.06.037","article-title":"High-Dose Irradiation in Combination With non-Ablative Low-Dose Radiation to Treat Metastatic Disease After Progression on Immunotherapy: Results of a Phase II Trial","volume":"162","author":"Patel","year":"2021","journal-title":"Radiother Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-4632","article-title":"A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition With Targeted Low-Dose or Hypofractionated Radiation for Patients With Metastatic Colorectal Cancer","volume":"27","author":"Monjazeb","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.08.025","article-title":"Use of Multi-Site Radiation Therapy for Systemic Disease Control","volume":"109","author":"Patel","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_159185","article-title":"Liver Metastases in Colorectal Cancer","volume":"35","author":"Folprecht","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.20517\/2394-5079.2020.37","article-title":"Can Radiotherapy Finally \u201cGo Live\u201d in the Management of Liver Metastases","volume":"6","author":"John RG","year":"2020","journal-title":"Hepatoma Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1748-717X-5-97","article-title":"Whole-Liver Radiotherapy for End-Stage Colorectal Cancer Patients With Massive Liver Metastases and Advanced Hepatic Dysfunction","volume":"5","author":"Yeo","year":"2010","journal-title":"Radiat Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2015.16.15.6381","article-title":"Whole Liver Palliative Radiotherapy for Patients With Massive Liver Metastases","volume":"16","author":"Edyta","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1673.2003.01177.x","article-title":"A Prospective Trial of Short-Fractionation Radiotherapy for the Palliation of Liver Metastases","volume":"47","author":"Bydder","year":"2003","journal-title":"Australas Radiol"},{"key":"B18","article-title":"Radiation Hepatitis","volume":"93","author":"Ingold","year":"1965","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1186\/s12885-019-6073-7","article-title":"Sites of Metastasis and Association With Clinical Outcome in Advanced Stage Cancer Patients Treated With Immunotherapy","volume":"19","author":"Bilen","year":"2019","journal-title":"BMC Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0325","article-title":"Liver Metastasis and Treatment Outcome With Anti-PD-1 Monoclonal Antibody in Patients With Melanoma and NSCLC","volume":"5","author":"Tumeh","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy041","article-title":"Nivolumab Versus Docetaxel in Previously Treated Advanced Non-Small-Cell Lung Cancer (CheckMate 017 and CheckMate 057): 3-Year Update and Outcomes in Patients With Liver Metastases","volume":"29","author":"Vokes","year":"2018","journal-title":"Ann Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0793","article-title":"Phase II Trial of Ipilimumab With Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses","volume":"7","author":"Welsh","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e001001","DOI":"10.1136\/jitc-2020-001001","article-title":"Pembrolizumab With or Without Radiation Therapy for Metastatic Non-Small Cell Lung Cancer: A Randomized Phase I\/II Trial","volume":"8","author":"Welsh","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ccr.2013.09.014","article-title":"Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS\u207a\/M1 Phenotype That Orchestrates Effective T Cell Immunotherapy","volume":"24","author":"Klug","year":"2013","journal-title":"Cancer Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052494","article-title":"Radiation Modulates the Peptide Repertoire, Enhances MHC Class I Expression, and Induces Successful Antitumor Immunotherapy","volume":"203","author":"Reits","year":"2006","journal-title":"J Exp Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","article-title":"Immunity, Tolerance and Autoimmunity in the Liver: A Comprehensive Review","volume":"66","author":"Doherty","year":"2016","journal-title":"J Autoimmun"},{"key":"B27","article-title":"Cancer Associated Fibroblasts: The Dark Side of the Coin","volume":"1","author":"Cirri","year":"2011","journal-title":"Am J Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.02.012","article-title":"The Bidirectional Crosstalk Between Metastatic Uveal Melanoma Cells and Hepatic Stellate Cells Engenders an Inflammatory Microenvironment","volume":"181","author":"Babchia","year":"2019","journal-title":"Exp Eye Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2 the Master Regulator of Fibrosis.Pdf","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13046-019-1110-6","article-title":"Collagens and Cancer Associated Fibroblasts in the Reactive Stroma and Its Relation to Cancer Biology","volume":"38","author":"Nissen","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-15-0307","article-title":"Cancer-Associated Fibroblasts Induce a Collagen Cross-Link Switch in Tumor Stroma","volume":"14","author":"Pankova","year":"2016","journal-title":"Mol Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.24593","article-title":"Bimodal Role of Kupffer Cells During Colorectal Cancer Liver Metastasis","volume":"14","author":"Wen","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune Responses in the Liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the Liver\u2013From Homeostasis to Disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00193","article-title":"Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment","volume":"10","author":"Menon","year":"2019","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver Metastasis Restrains Immunotherapy Efficacy via Macrophage-Mediated T Cell Elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.07.1660","article-title":"Low-Dose Radiation Decreases Cancer-Associated Fibroblasts and May Increase T-Cell Trafficking Into Tumors","volume":"108","author":"Patel","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03614-z","article-title":"Hepatic Stellate Cells Suppress NK Cell-Sustained Breast Cancer Dormancy","volume":"594","author":"Correia","year":"2021","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.812210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T06:13:16Z","timestamp":1639548796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.812210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2021.812210"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.812210","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,15]]},"article-number":"812210"}}